Ryan Z. Turncliff

1.3k total citations
24 papers, 1.1k citations indexed

About

Ryan Z. Turncliff is a scholar working on Cellular and Molecular Neuroscience, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Ryan Z. Turncliff has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Oncology. Recurrent topics in Ryan Z. Turncliff's work include Drug Transport and Resistance Mechanisms (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Ryan Z. Turncliff is often cited by papers focused on Drug Transport and Resistance Mechanisms (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Neurotransmitter Receptor Influence on Behavior (5 papers). Ryan Z. Turncliff collaborates with scholars based in United States, Switzerland and Ireland. Ryan Z. Turncliff's co-authors include Kim L. R. Brouwer, Elliot Ehrich, Bernard L. Silverman, Peter J. Meier, Gary M. Pollack, Yangchun Du, Keith Hoffmaster, Nita Patel, Maciej J. Zamek‐Gliszczynski and Hao Xiong and has published in prestigious journals such as Gastroenterology, Journal of Pharmacology and Experimental Therapeutics and Neuropsychopharmacology.

In The Last Decade

Ryan Z. Turncliff

23 papers receiving 1.0k citations

Peers

Ryan Z. Turncliff

ONCOL

PPCH

PHARM

PMH

PHARM

Edward J. Randinitis United States

Albert D. Fraser Canada

Christoph Wandel United States

Steven Troy United States

David J. Greenblatt United States

Jutta Darimont Germany

Angela Seeringer Germany

Werner Steimer Germany

Willi Cawello Germany

Heidi L. Liston United States

Edward J. Randinitis United States

Ryan Z. Turncliff

265 ×0.7

ONCOL

371 ×1.6

PPCH

232 ×1.1

PHARM

246 ×1.3

PMH

194 ×1.1

PHARM

Citations per year, relative to Ryan Z. Turncliff Ryan Z. Turncliff (= 1×) peers Edward J. Randinitis

Countries citing papers authored by Ryan Z. Turncliff

Since Specialization

Citations

This map shows the geographic impact of Ryan Z. Turncliff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Z. Turncliff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Z. Turncliff more than expected).

Fields of papers citing papers by Ryan Z. Turncliff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan Z. Turncliff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Z. Turncliff. The network helps show where Ryan Z. Turncliff may publish in the future.

Co-authorship network of co-authors of Ryan Z. Turncliff

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan Z. Turncliff. A scholar is included among the top collaborators of Ryan Z. Turncliff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan Z. Turncliff. Ryan Z. Turncliff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shram, Megan J., Bernard L. Silverman, Elliot Ehrich, Edward M. Sellers, & Ryan Z. Turncliff. (2015). Use of Remifentanil in a Novel Clinical Paradigm to Characterize Onset and Duration of Opioid Blockade by Samidorphan, a Potent μ-Receptor Antagonist. Journal of Clinical Psychopharmacology. 35(3). 242–249. 49 indexed citations

Turncliff, Ryan Z., Marjie Hard, Yangchun Du, Robert Risinger, & Elliot Ehrich. (2014). Relative bioavailability and safety of aripiprazole lauroxil, a novel once-monthly, long-acting injectable atypical antipsychotic, following deltoid and gluteal administration in adult subjects with schizophrenia. Schizophrenia Research. 159(2-3). 404–410. 33 indexed citations

Turncliff, Ryan Z., Lauren DiPetrillo, Bernard L. Silverman, & Elliot Ehrich. (2014). Single- and Multiple-dose Pharmacokinetics of Samidorphan, A Novel Opioid Antagonist, in Healthy Volunteers. Clinical Therapeutics. 37(2). 338–348. 32 indexed citations

Ehrich, Elliot, Ryan Z. Turncliff, Yangchun Du, et al.. (2014). Evaluation of Opioid Modulation in Major Depressive Disorder. Neuropsychopharmacology. 40(6). 1448–1455. 131 indexed citations

Turncliff, Ryan Z., et al.. (2012). P.3.c.024 ALKS 9070, a novel once monthly prodrug of aripiprazole, achieves therapeutic levels and is well-tolerated in adults with schizophrenia. European Neuropsychopharmacology. 22. S330–S331. 3 indexed citations

Dean, Reginald L., et al.. (2011). Effects of oral loperamide on efficacy of naltrexone, baclofen and AM-251 in blocking ethanol self-administration in rats. Pharmacology Biochemistry and Behavior. 100(3). 530–537. 10 indexed citations

DiPetrillo, Lauren, Richard Leigh-Pemberton, Aslı Memişoğlu, et al.. (2011). ALKS 37, A Novel, Peripherally-Restricted Opioid Receptor Antagonist, Demonstrates Efficacy in the Treatment of Opioid-Induced Bowel Dysfunction.. Gastroenterology. 140(5). S–136.

Turncliff, Ryan Z., et al.. (2010). ALKS 27 (Trospium Inhalation Powder) Improves Lung Function Following Single Administration In Subjects With COPD. A4457–A4457. 6 indexed citations

Todtenkopf, Mark S., et al.. (2009). PRECLINICAL STUDY: Route of administration affects the ability of naltrexone to reduce amphetamine‐potentiated brain stimulation reward in rats. Addiction Biology. 14(4). 408–418. 17 indexed citations

10.

Dunbar, Joi, et al.. (2007). Population Pharmacokinetics of Extended-Release Injectable Naltrexone (XR-NTX) in Patients With Alcohol Dependence. Journal of Studies on Alcohol and Drugs. 68(6). 862–870. 17 indexed citations

11.

Turncliff, Ryan Z., et al.. (2006). Effect of culture conditions on the expression and function of Bsep, Mrp2, and Mdr1a/b in sandwich-cultured rat hepatocytes. Biochemical Pharmacology. 71(10). 1520–1529. 45 indexed citations

12.

Dunbar, Joi, Ryan Z. Turncliff, Qunming Dong, et al.. (2006). Single‐ and Multiple‐Dose Pharmacokinetics of Long‐acting Injectable Naltrexone. Alcoholism Clinical and Experimental Research. 30(3). 480–490. 94 indexed citations

13.

Turncliff, Ryan Z., Keith Hoffmaster, J. Cory Kalvass, Gary M. Pollack, & Kim L. R. Brouwer. (2006). Hepatobiliary Disposition of a Drug/Metabolite Pair: Comprehensive Pharmacokinetic Modeling in Sandwich-Cultured Rat Hepatocytes. Journal of Pharmacology and Experimental Therapeutics. 318(2). 881–889. 25 indexed citations

14.

Turncliff, Ryan Z., Joi Dunbar, Qunming Dong, et al.. (2005). Pharmacokinetics of Long‐Acting Naltrexone in Subjects With Mild to Moderate Hepatic Impairment. The Journal of Clinical Pharmacology. 45(11). 1259–1267. 24 indexed citations

15.

Turncliff, Ryan Z., Peter J. Meier, & Kim L. R. Brouwer. (2004). EFFECT OF DEXAMETHASONE TREATMENT ON THE EXPRESSION AND FUNCTION OF TRANSPORT PROTEINS IN SANDWICH-CULTURED RAT HEPATOCYTES. Drug Metabolism and Disposition. 32(8). 834–839. 50 indexed citations

16.

Hoffmaster, Keith, Ryan Z. Turncliff, Edward L. LeCluyse, et al.. (2004). P-glycoprotein Expression, Localization, and Function in Sandwich-Cultured Primary Rat and Human Hepatocytes: Relevance to the Hepatobiliary Disposition of a Model Opioid Peptide. Pharmaceutical Research. 21(7). 1294–1302. 121 indexed citations

17.

Zamek‐Gliszczynski, Maciej J., Hao Xiong, Nita Patel, et al.. (2003). Pharmacokinetics of 5 (and 6)-Carboxy-2′,7′-Dichlorofluorescein and Its Diacetate Promoiety in the Liver. Journal of Pharmacology and Experimental Therapeutics. 304(2). 801–809. 143 indexed citations

18.

Swan, Suzanne K., K. Wilner, Joyce Sherwood, et al.. (2000). The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function. British Journal of Clinical Pharmacology. 49(S1). 27–33. 24 indexed citations

19.

Everson, Gregory T., Kenneth C. Lasseter, Karl E. Anderson, et al.. (2000). The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function. British Journal of Clinical Pharmacology. 49(S1). 21–26. 31 indexed citations

20.

Wilner, Keith D., et al.. (2000). Single‐ and multiple‐dose pharmacokinetics of ziprasidone in healthy young and elderly volunteers. British Journal of Clinical Pharmacology. 49(S1). 15–20. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact